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In vivo confocal microscopy (IVCM) is a non-invasive imaging technique facilitating real-time acquisition 
of images from the live cornea and its layers with high resolution (1–2 µm) and high magnification (600 
to 800-fold). IVCM is extensively used to examine the cornea at a cellular level, including the subbasal 
nerve plexus (SBNP). IVCM of the cornea has thus gained intense interest for probing ophthalmic and 
systemic diseases affecting peripheral nerves. One of the main drawbacks, however, is the small field 
of view of IVCM, preventing an overview of SBNP architecture and necessitating subjective image 
sampling of small areas of the SBNP for analysis. Here, we provide a high-quality dataset of the corneal 
SBNP reconstructed by automated mosaicking, with an average mosaic image size corresponding to 48 
individual IVCM fields of view. The mosaic dataset represents a group of 42 individuals with Parkinson’s 
disease (PD) with and without concurrent restless leg syndrome. Additionally, mosaics from a control 
group (n = 13) without PD are also provided, along with clinical data for all included participants.
Background & Summary
Neurological disorders are a significant cause of disability and death worldwide. In the period from 1990 to 
2015, the number of deaths from neurological disorders increased by 36.7%, with Parkinson’s disease (PD) con-
stituting the 12th most common condition leading to premature death (1.2%) among all neurological disorders 
in the overall global burden from neurological disorders in 20151.
PD is a progressive neurodegenerative disorder with its diagnosis based on clinical criteria consisting of a 
combination of bradykinesia with rigidity and/or rest tremor2. Peripheral neuropathy (PN) that occurs in PD 
can exhibit both small and large fiber involvement3,4. Additionally, restless legs syndrome (RLS), a sensorimotor 
condition, is frequently reported among patients suffering from neurological disorders including PD; therefore 
occurrence of RLS as comorbidity in PD patients has been the focus of multiple studies5–8. As PN is difficult to 
diagnose, there has been much interest in the development and refinement of non-invasive examination modal-
ities for its potential diagnosis. Increasingly, quantitative measures derived from non-invasive peripheral nerve 
imaging in the corneal subbasal nerve plexus are being reported as putative indicators of small fiber peripheral 
neuropathy in conditions such as diabetes mellitus9–17. This technique is therefore of interest in the context of 
PD and RLS.
The cornea is a densely innervated tissue, whose sensory nerve bundles enter the cornea at the mid-stroma 
in a radial formation from the periphery18–21. The stromal branches extend towards the central anterior cornea, 
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penetrate Bowman’s layer, and then individual nerve fiber bundles separate and run parallel to the corneal sur-
face, at the level of the corneal basal epithelium, forming the sub-basal nerve plexus (SBNP) supplying the 
sensory nerve fibers to the corneal epithelium18,20,22. In vivo confocal microscopy (IVCM) is a clinical method of 
non-invasively examining the cornea, providing images with high lateral (1–2 µm) and axial (5–10 µm) resolu-
tion, at a magnification of up to 60023 to 800 times24. IVCM provides excellent images of the SBNP, from which 
parameters such as corneal nerve fiber length density (CNFL, measured as the sum of the nerve fiber length in 
mm divided by the corresponding SBNP area in mm2), corneal nerve fiber number density (CNFD, the number 
of distinct nerve fibers (defined in various ways) per mm2 of SBNP area), corneal nerve branch density (CNBD, 
the number of nerve branching points per mm2 of SBNP area), and tortuosity (defined in various ways) can be 
measured10,16,18,20,25,26. Only a few studies have used IVCM to examine corneal nerves in PD with some contra-
dictory results. One study included 26 PD patients with varying disease duration and 26 controls. Using IVCM 
and selecting 4 to 6 single field-of-view images per eye for analysis, reduced CNFD, but increased CNBD and 
CNFL were found, compared to (healthy) controls27. Another IVCM study, including 26 patients with early PD 
and 22 controls, analyzed 4 to 8 single field-of-view IVCM images of the SBNP per subject. The authors of the 
study reported that CNFL and CNBD were significantly reduced in PD patients compared to controls, while 
CNFD reduction was not statistically significant28. Another study assessing 15 patients with moderate PD and 15 
healthy controls, did not report the number of IVCM images analyzed per eye, but found a significant reduction 
in CNFL in PD patients relative to controls29.
Here we present an IVCM dataset representing a larger number of patients (n = 42) compared to prior IVCM 
studies of PD. The raw data in this dataset was originally used30 to investigate a possible relationship between 
the presence of RLS in PD and corneal nerve parameters. Here we provide an entire dataset of high quality 
wide-field mosaics of the corneal SBNP in PD patients (21 with and 21 without RLS) and 13 age-matched con-
trols. We also provide the relevant clinical diagnostic information alongside the SBNP mosaics. The high quality 
wide-field mosaic images are a unique distinguishing feature in the present dataset, relative to prior IVCM 
studies. Our dataset represents the largest SBNP image sizes published to date, from any clinical cohort. The 
use of mosaics avoids the subjective selection of individual fields of view thus providing an objective view of 
the overall SBNP architecture, enabling accurate analysis of SBNP patterns and exact quantification of SBNP 
parameters16,31. It has previously been shown that not using mosaics of the SBNP but using only small numbers 
of hand-selected images can lead to very large errors in the values of reported parameters31, possibly explaining 
wide discrepancies in previously reported values of SBNP in PD populations.
Moreover, inflammation is considered as one of the important etiological processes in PD as a neurodegener-
ative disease32–34. The mosaic dataset provided here additionally contains inflammatory cell parameters that can 
be further analyzed for their relation to the various clinical disease parameters. To the best of our knowledge, no 
prior study in PD has investigated the inflammatory cells that are clearly visible at the level of the SBNP, although 
in other conditions these inflammatory cells (such as antigen-presenting dendritic cells) have been shown to be 
related to the onset of disease35.
Methods
Study design, participants, inclusion and exclusion criteria. The initial study from which the raw 
IVCM data was collected30 had a cross-sectional design, where participants were enrolled in the period from 
Spring 2018 to Autumn 2019 at the outpatient clinic at Center for Neurology and Karolinska University Hospital, 
Stockholm, Sweden. The study encompassed control participants without PD, and PD patients with (PD + RLS) 
and without RLS (PD-RLS) matched for age and sex. Participants were aged between 50 and 80 years and had to 
have one eye without history of previous corneal trauma, surgery or ongoing eye drop treatment. Patients fulfilled 
a diagnosis of clinically probable PD with or without RLS according to established criteria2,36. PD + RLS (n = 21), 
PD − RLS (n = 21) and controls (n = 13) comprised the study. Written informed consent was obtained from all 
participants and the study was approved by the regional ethical board of Stockholm, Sweden (ref. nr 2018/264-
31/2 (2019-03158)). Inclusion and exclusion criteria have been previously described in detail30.
Clinical assessments. Details of the clinical, neurophysiological and biochemical assessments are out-
lined in our original study report30. In short, demographic and disease-specific parameters were obtained by 
oral interview. Neurological rating scales included modified Hoehn and Yahr staging (mH&Y)37,38 and the Utah 
Early Neuropathy Scale (UENS)39. The severity of RLS symptoms was evaluated with the International Restless 
Legs Scale rating scale (IRLS)40 and the sensory suggested immobilization test was performed in the PD + RLS 
group41,42. With regard to electrodiagnostic and quantitative sensory testing, details are described in the original 
study report30.
In Vivo Confocal Microscopy examination. In vivo confocal microscopy of the cornea was performed 
to visualize the peripheral small fiber morphology of the corneal SBNP. IVCM image acquisition was conducted 
in both eyes of all participants, or in one eye in cases where the other eye did not meet the inclusion criteria. A 
single, experienced examiner performed all examinations using a Heidelberg Retinal Tomograph 3 with Rostock 
Corneal Module, HRT3-RCM (Heidelberg Engineering, Germany), using a built-in fixation light to bring the 
focus on to the central cornea. A motorized joystick module was used to control and maintain the focal plane 
at the desired corneal depth, at the SBNP level. The central and paracentral corneal regions were first imaged 
by translating the microscope field of view manually in a raster pattern, until regions were reached where the 
curvature of the cornea resulted in oblique images. Subsequently, to image the paracentral regions, the fixation 
light was moved sequentially in superior, inferior, temporal and nasal direction, with the manual raster scanning 
process being repeated for each fixation light position. During scanning, the depth of the SBNP was maintained 
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by manually adjusting the depth of focus by small movements on the joystick, in order to capture subtle variations 
in the plexus and enable a maximal projection of nerves to be made onto a 2D plane, as previously described31.
Differing from prior work, however, during the clinical examinations an attempt was made to image as large 
a wide-field area of the SBNP as possible by periodically pausing the examination to allow the subject and exam-
iner to rest, then resuming the examination, until the examiner judged the imaged area to be of sufficient extent 
and quality, provided the subject was willing to cooperate with the strategy. The raw image datasets obtained 
from IVCM examination were then used as input to automated mosaic generation and nerve detection and 
quantification algorithms (described below).
Automated mosaic image generation. The process used to assemble SBNP mosaic images from 
the acquired datasets is identical to the method described in previous studies16,31, with one notable exception 
described below. The mosaic generation process consisted of four consecutive process steps:
 1. Removal of non-SBNP images from the dataset,
 2. Pairwise, correlation-based image registration (using a decomposition of the images into 12 horizontal 
rectangular sub-images),
 3. Formation and solution of a system of linear equations, yielding position coordinates of the sub-images, 
and
 4. Construction of the mosaic image.
As it is not always possible to avoid the inclusion of non-SBNP images in the acquired datasets, these images 
were first removed from the processed data. The benefit of this is twofold. Non-SBNP images could negatively 
influence the contrast of the relevant SBNP image features if included in the mosaic algorithm, and removal of 
such images reduces mosaic-processing time if excluded early in the processing pipeline. Whereas the exclusion 
of non-SBNP images had been done manually in the past31, a tissue classification algorithm43 was used in the 
initial PD30 study to automatically identify and exclude non-SBNP images. The classifier is based on the Bag of 
Visual Words approach. It uses a trained feature extraction followed by a set of support vector machines, each of 
which had been trained to separate one characteristic corneal tissue class (epithelium, SBNP, stroma) from any 
other tissue class. A previous quantitative evaluation of the classifier reported a classification accuracy of over 
96% on a manually labeled set of 663 IVCM images43.
The image registration step makes use of the phase correlation function, a well-established approach for 
calculating the relative offset between two images44. The phase correlation was calculated for all possible image 
pairs of a dataset to establish an estimation of the translational alignment between each image pair, but the key 
step in creating high-quality mosaic images is the decomposition of each image into 12 horizontal slices or 
sub-images and the calculation of the relative alignment dij (relating to the sub-images with indices i and j)31,45. 
This approach was designed to analyze specifically the characteristic motion-induced image deformation arti-
facts that arise from the image formation process of the HRT-RCM microscope.
The third step of the mosaic generation process was the deduction of absolute, global position coordinates pi 
for the sub-images from the translation vectors dij that had been calculated in the registration step. This global 
alignment process is based on the observation, that the translation vectors effectively estimate the position dif-
ferences between respective sub-images, = −d p pij j i
31,45. After excluding all sub-image registration results with 
a correlation value below an empirically predefined threshold, these equations form a system of linear equations. 
The linear equation system always possesses degrees of freedom that need to be addressed by additional regular-
ization terms: An additional equation λ =p 01 0  complements the otherwise purely difference equations with an 
absolute reference, and equations λ − =+p p( ) 0i i2 1  (limited to pairs (i, i + 1) of sub-images that belong to the 
same original image) provide alignment information for sub-images without any accepted registrations; λ1 and 
λ2 are weight factors. The regularized system of linear equations is subsequently solved for the sub-image posi-
tion coordinates pi.
The final mosaic image construction step was implemented as described previously31. Appropriate interpola-
tion between the sub-image positions pi yields position coordinates for single image rows, and the final mosaic 
image was then calculated by weighted averaging of overlapping original image data.
Optimizations of the mosaic image generation process. Runtime considerations were not a priority 
in the context of the present dataset. However, with regard to potential application in routine clinical practice 
(and also with regard to a larger number of patients in the future), the mosaic image generation process was 
reexamined with a particular focus on runtime optimization. The most effective means to reduce runtime is a 
size reduction of the images in the context of the image registration step, as the calculation time of the correla-
tion function is dependent on the size of the input data. However, reducing the image information used for the 
correlation function inherently increases the noise level of the correlation function, making it harder to reliably 
separate correct registration results from incorrect ones. Scale factors of 3 and 2 for full image and sub-image 
correlations, respectively, have proven to be a good compromise.
Automated nerve tracing and nerve parameter quantification in SBNP mosaics. The algorithm 
used for automated nerve fiber tracing in mosaics was described earlier by Guimarães et al.46. Briefly, this algo-
rithm is based on three main steps: pre-processing, classification and post-processing. The pre-processing aims 
to improve the visibility of the corneal nerves. To achieve this goal, a Top-Hat morphological filtering was used 
to equalize the background and to improve the contrast of the image. A bank of log-Gabor filters, each with a 
different orientation, highlights linear structures and completes the pre-processing. A threshold was then applied 
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to identify pixels corresponding to a nerve. From the selected pixels, morphological and intensity-based features 
are extracted and used as input for a finer classification based on the support vector machines approach. The final 
classification consists in a label “nerve” or “other” assigned to each pixel of the image. A binary image was then 
obtained, in which white pixels correspond to nerves and black pixels correspond to the other.
The resulting binary image contains nerve segments with small gaps between each other, due to noise in the 
original image. Thus, to improve the nerve tracing, the post-processing step performs morphological operations 
and traces missing connections47. In addition, the algorithm computes all possible connection-paths between 
segments based on distance, angle, and intensity. The best connection-path is then chosen based on the Dijkstra 
algorithm48.
From the automated nerve tracing, quantitative nerve parameters were extracted. For the current mosaic 
dataset, the algorithm provided the mosaic corneal nerve fiber length density (mCNFL), defined as the total 
length of all nerves in the mosaic divided by the mosaic area (black regions excluded) expressed in mm/mm2, 
and the mosaic corneal nerve branching density (mCNBD) defined as the total number of branching points 
divided by the mosaic area (black region excluded) expressed as the number of branching points per mm2.
The inferocentral whorl region of the subbasal plexus normally contains the highest concentration of subba-
sal nerves, and this region has been analyzed separately in several studies31,49–51. Here, subbasal nerve parameters 
Parameter Description
Subject ID Identification number assigned to each of the subjects in the study cohort (1 to 57)
Image name File name assigned to each image in the wide-field mosaics dataset
Eye Image and clinical data corresponding to right eye (RE) or left eye (LE)
Mosaic area Area of the corneal subbasal nerve plexus represented in the mosaic image (mm
2). In all cases, regions without image data 
(black or empty areas) were not included in the area calculation.
mCNFL Mosaic corneal nerve fiber length density: the total length of all nerves in the mosaic divided by the mosaic area expressed in (mm/mm2)
mCNBD Mosaic corneal nerve branch density; defined as total number of branching points divided by the mosaic area and expressed as the number of branching points per mm2 (nr./ mm2)
wCNFL
Whorl corneal nerve fiber length density; defined as corneal subbasal nerve fiber length density in the whorl region (in mm/
mm2), based on automated nerve tracing. wCNFL is provided for 800 µm and 400 µm diameter whorl regions in full and half-
circle areas (see Fig. 3). Only values for eyes where the full circle contained image data are included.
wCNBD
Whorl corneal nerve branch density defined as total number of branching points in the whorl region divided by the mosaic 
area expressed as the number of branching points per mm2. wCNBD is provided for the four different definitions of the whorl 
as for wCNFL.
mDCs Density of mature dendritic cells in each mosaic, in cells/mm2 of mosaic area.
imDCs Density of immature dendritic cells in each mosaic, in cells/mm2 of mosaic area.
GCs Density of globular cells in each mosaic, in cells/mm2 of mosaic area.
Table 1. Study parameters related to the IVCM data obtained and provided in the mosaic dataset.
Parameter Description
Subject ID Identification number of the subject in the cohort (57 subjects of which 2 were excluded).
Study Group Controls, PD + RLS, or PD − RLS
Age Subject age at time of study inclusion (years)
Sex 1 = Male, 0 = Female
Smoking Smoking status, 1 = yes, 0 = no
Coffee intake Consumption of coffee (cups/day)
Intake of B12 supplements or multivitamins 1 = yes, 0 = no
PD motor duration Duration of motor symptoms (years)
RLS duration Duration of restless legs syndrome (years)
L-dopa duration Duration of treatment with L-dopa (years)
LEDD L-dopa equivalent daily dose (mg)
Ongoing L-dopa therapy 1 = yes, 0 = no
mH&Y (stage) Modified Hoehn and Yahr scale for staging Parkinson’s symptoms and disability
IRLS International RLS study group rating scale (IRLS): 0–40
UENS Utah Early Neuropathy Scale. Clinical rating scale for the assessment of peripheral neuropathy.
p-homocysteine Concentration of homocysteine in plasma (μmol/L)
s-methylmalonic acid Concentration of methylmalonic acid in serum (μmol/L)
p-pyridoxal-5′-phosphate Concentration of pyridoxal-5′-phosphate in plasma (nmol/L)
s-ferritin Concentration of ferritin in serum (μg/L)
Table 2. List of clinical and demographic parameters linked to each study subject in the provided data set. 
Blood parameters were based on fasting whole blood samples acquired using venipuncture. L-dopa: Levodopa.
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in the whorl region were analyzed by the automated tracing algorithm described above. Whorl corneal nerve 
fiber length (wCNFL) and whorl corneal nerve branch density (wCNBD) in the whorl region were automatically 
calculated from automated tracing with respect to four configurations; for nerves within a full circular region 
centered on the whorl center with either an 800 µm diameter or 400 µm diameter, and for the corresponding 
superior semi-circular regions (extending from 9 to 3 o’clock) only. Nerve analyses were performed across con-
trol, PD − RLS and PD + RLS groups, and again for controls vs. all PD participants.
Inflammatory cell analysis within the SBNP. Additionally, it is possible to analyze the mosaic dataset 
for the presence of inflammatory cells/dendritic cells (DCs), and with respect to the different DC subtypes whose 
morphologic features have been described in an earlier study35. Here, two independent experienced observers 
performed morphological characterization and quantification of the inflammatory DCs present in the SBNP. 
The two observers were masked to the identity of each mosaic image. Three types of DCs were quantified: mature 
DCs, immature DCs and globular cells35. The DC density values, expressed as cells per mm2 of mosaic area for 
the various subtypes, were averaged across observers and across both eyes for all participants. This data is also 
provided along with the mosaic dataset.
Statistical analysis. Statistical analyses of presented data were performed using IBM SPSS statistics 
for Windows, version 25.0 (IBM Corp., Armonk, N.Y., USA). A two-tailed P value of < 0.05 was considered 
significant.
Data Records
Data for the wide field mosaic images of the corneal subbasal plexus that were acquired for PD patients and 
control participants are provided52. The Excel file contains the numeric data and the corresponding mosaic 
image numbers, and is therefore the ‘key’ to the mosaic image dataset. IVCM mosaic images represent the largest 
mosaic per eye and are provided in TIFF format, labeled with the subject ID number (01 to 57 – two participants 
were excluded hence non-consecutive numbering) and the eye (RE for right eye and LE for left eye). Table 1 
details the parameters associated with the SBNP mosaic dataset. In addition, we provide in the same file the 
clinical parameters linked to each study subject (Table 2). Finally, we provide folders for each eye (in ZIP format) 
containing the raw, non-stitched IVCM images used to create each corresponding mosaic image.
Fig. 1 Characterization of mosaic computation and size. (a) Scatter plot for run-times for mosaic image generation 
in relation to mosaic image size. (b) Histogram of distribution of number of mosaics for each enhancement factor 
(enhancement factor is mosaic area divided by the area of a single 400 × 400 μm IVCM frame).
Fig. 2 Representative IVCM mosaic images of the corneal subbasal nerve plexus for the three study groups.  
(a) Control. (b) Subject with PD with RLS. (c) Subject with PD without RLS.
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Technical Validation
The average (mean ± standard deviation) percentage of SNP-classified images from a given eye was 59.2 ± 15.8%. 
The overall runtime of the mosaic image generation process is dominated by the image registration step, which 
exhibits a quadratic runtime behavior with respect to the SBNP-filtered dataset size when registering all possi-
ble image pairs. The following overall runtimes are therefore not normally distributed and are given as median 
(interquartile range). The overall runtime measured in the study process pipeline (i.e. not applying the runtime 
optimizations), was 88.6 (45.8, 166.1) minutes per eye (Fig. 1a). After employing the runtime optimizations, 
particularly including scaling down the images prior to phase correlation, the runtime of the entire process 
decreased to 3.0 (1.6, 5.7) minutes per eye. The resulting mosaic image quality was comparable with both 
approaches, as examined by visual comparison. Figure 1 shows a scatter plot of the runtime for mosaic gen-
eration in relation to the size of respective mosaic images in the study cohort, and to the number of individual 
raw IVCM images used to generate each corresponding mosaic. Runtimes are based on a Windows PC system 
(Core2 Duo, E8400, 2 × 3 GHz, 6GB RAM).
The average (mean ± standard deviation) mosaic size per eye was 7.69 ± 3.53 mm² across a total of 106 mosa-
ics, for the original process used for study evaluation. This corresponds to a mean enhancement factor of 48 
across all 106 mosaics, meaning an equivalent mean tiled area of 48 individual IVCM image frames. Figure 1b 
shows the distribution of the number of mosaics with corresponding enhancement factor in the present dataset. 
Fig. 3 Mosaic image illustrating regions analyzed for inferocentral whorl parameter wCNFL. (a) Mosaic image 
depicting region of 800 μm radius (blue) and 400 μm radius (magenta) centered on the whorl center. (b) Mosaic 
image depicting upper half circle of 800 μm radius (blue) and 400 μm radius (magenta) based on the whorl 
center.
Fig. 4 Box plots comparing mCNFL among the study groups. (a) Box plot comparing healthy controls vs. all 
Parkinson’s disease (PD) patients as a single group, t-test P = 0.62. (b) Box plot comparing all study subgroups 
including PD patients with and without RLS, ANOVA P = 0.79. Data represents quantification based on the 
single largest mosaic per eye, differing slightly from prior analyses where in some cases average values from 
several mosaics per eye were used30.
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The data presented here represents the mosaic with the largest size for each eye, differing slightly from prior 
analyses where in some cases average values from several mosaics per eye were used30. It is interesting to note 
that using the runtime-optimized algorithms, the average size of the largest mosaic image for a given eye 
decreased to 7.15 ± 3.30 mm², with either no area reduction or an area reduction of less than 5% of the original 
mosaic image area in 69% of the mosaics. It is worth noting that – for both the optimized and the non-optimized 
process alike – the original images that could not be integrated into the single largest mosaic image per eye are 
still assembled into separate, smaller mosaic images. Figure 2(a–c) shows representative SBNP mosaics from the 
control, PD + RLS and PD − RLS groups.
Figure 3(a,b) depicts examples of the automatically traced mosaics. The traced nerves and identified branch-
ing points were quantified with respect to the entire mosaic image area, as well as the plexus area limited to the 
Fig. 5 Box plots indicating comparisons of wCNFL across study groups. (a,b) Comparison of wCNFL across 
the three study groups. (a) Full circular whorl region of 800 μm diameter, ANOVA P = 0.47. (b) Half-circle 
region of 800 μm diameter, ANOVA P = 0.77. (c,d) The corresponding box plots for the whorl defined in a  
400 μm diameter region. (c) Full circular whorl region of 400 μm diameter, ANOVA P = 0.36. (d) Half-circle 
region of 400 μm diameter, ANOVA P = 0.47.
Inflammatory cell type
mDCs imDCs GCs
Mean difference 9.3 −4.9 −0.8
SD 12.7 30.0 2.6
Lower 95% LOA −15.6 −63.8 −5.9
Upper 95% LOA 34.3 54.0 4.3
Pearson’s r 0.68 0.74 0.98
Table 3. Overview of inter-observer differences in dendritic cell quantification from mosaic images. Values 
represent the mean difference between the two observers, standard deviation of difference and lower and upper 
bounds of the 95% limits of agreement (LOA) for dendritic cell density in cells/mm2 of mosaic area, for each 
given cell type. Identification and quantification of inflammatory cells was based on three cell types: mDCs: 
Mature dendritic cells, imDCs: immature dendritic cells, and GCs: globular cells. The correlation coefficient 
between observers (Pearson’s r) is shown for each cell type.
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indicated whorl regions. We provide the nerve parameter data for these analyses as part of the current dataset. 
Example comparisons of mCNFL and wCNFL across the various groups are given in Fig. 4(a,b) and Fig. 5(a–d).
The validity of the manual inflammatory cell quantification in mosaics by the two observers was determined 
by the Bland-Altman analysis method of inter-observer agreement53. The mean, standard deviation (SD) and 
the 95% limits of agreement (LOA) between observers for the difference in cell density for each cell type across 
all mosaics is presented in Table 3, along with the correlation between observers measured by Pearson’s r. As 
an example of the inflammatory cell data, the density of mature and immature dendritic cells (mDCs, imDCs, 
respectively), and globular cells (GCs) are plotted across the three subject groups (Fig. 6a–c).
Code availability
Computational codes used to, firstly, perform the depth-corrected mosaics synthesis used in the study and, 
secondly, for automated nerve tracing were developed by the academic institutions of Karlsruhe Institute of 
Technology and University of Padua, respectively, and are exclusively intended for scientific research use30,31. 
The developers of the respective algorithms are willing to apply the code to user-supplied raw IVCM data in the 
form of academic collaborations. Interested parties are requested to contact the respective researchers for mosaic 
creation (Allgeier) and automated nerve analyses (Scarpa).
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